When we became our own company, abbvie formed a new kind of enterprise—a biopharmaceutical company We blend the stability, global scale, resources and commercial capabilities of a pharmaceutical company with the focus and culture of a biotech. Abbvie’s power play the worry with abbvie was that once the humira patent expired, this would be a business in huge decline Well, the patent expired and two new drugs took the torch Abbvie is committed to helping patients get the medicines they need That’s why we offer patient assistance programs that provide free abbvie medicines to qualifying patients.
For the third straight quarter, abbvie has jacked up its revenue forecast for 2025 The illinois drugmaker has raised its guidance by $400 million, now expecting sales to reach $60.9 billion. Abbvie 's (abbv 4.45%) products are regularly used to help heal the sick, but the company's stock wasn't healthy for portfolios on friday The company published its latest quarterly earnings.
WATCH
